Volume : 09, Issue : 01, January – 2022
Title:
22.REVIEW STUDY: POLYMORPHISM IDENTIFIED IN SEPSIS INDUCED ACUTE KIDNEY INJURY
Authors :
Reda Goweda, Abdulrahim Ahmad A Almasabi, Thamer Mishal M Alqurashi, Faisal Besheit H Almatrafi , Mohamed Saad Aljuaid, Faisal Masoud Almatrafi, Rakan Mohammad Alotaibi
Abstract :
Background: Sepsis-induced acute kidney injury (S-AKI) is a typical complexity in hospitalized and basically sick patients, which expands the danger of creating constant comorbidities and is related with incredibly high mortality.
Objective: This study aimed at providing an update on polymorphism identified in sepsis induced acute kidney injury.
Methods: The online database was searched then the articles were evaluated then all the eligible English studies during the last 10years were included in the study.
Results:there were 31 studies included focusing on the association between gene polymorphism and AKI induced by sepsis in which 13 gene polymorphisms were studied.
Conclusion: The genetic structure of the individuals can impact the vulnerability and severity of AKI. Most of the gene polymorphisms can’t induce AKI alone but can act with other genetic disturbances and depends on the health state of patients and their compromised state. Thus, AkI is supposed to be influenced by genetic factors with different pathological pathways.
Keywords: polymorphism, sepsis induced acute kidney injury
Cite This Article:
Please cite this article in press Reda Goweda et al, Review Study: Polymorphism Identified In Sepsis Induced Acute Kidney Injury., Indo Am. J. P. Sci, 2022; 09(01).
Number of Downloads : 10
References:
1. Bouchard J, Acharya A, Cerda J, Maccariello ER, Madarasu RC, Tolwani AJ, et al. A Prospective International Multicenter Study of AKI in the Intensive Care Unit. Clinical journal of the American Society of Nephrology : CJASN. 2015;10(8):1324-31.
2. Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive care medicine. 2015;41(8):1411-23.
3. Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, et al. Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive care medicine. 2011;37(2):241-8.
4. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive care medicine. 2013;39(2):165-228.
5. Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, et al. Acute kidney injury in sepsis. Intensive care medicine. 2017;43(6):816-28.
6. Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G, et al. Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive care medicine. 2009;35(5):871-81.
7. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative w. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-R12.
8. Cardinal-Fernández P, Nin N, Lorente JA. Acute lung injury and acute respiratory distress syndrome: a genomic perspective. Med Intensiva. 2011;35(6):361-72.
9. Susantitaphong P, Perianayagam MC, Tighiouart H, Liangos O, Bonventre JV, Jaber BL. Tumor necrosis factor alpha promoter polymorphism and severity of acute kidney injury. Nephron Clin Pract. 2013;123(1-2):67-73.
10. Li X, Mu G, Song C, Zhou L, He L, Jin Q, et al. Role of M2 Macrophages in Sepsis-Induced Acute Kidney Injury. Shock. 2018;50(2):233-9.
11. Jaber BL, Rao M, Guo D, Balakrishnan VS, Perianayagam MC, Freeman RB, et al. Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine. 2004;25(5):212-9.
12. Dalboni MA, Quinto BMR, Grabulosa CC, Narciso R, Monte JC, Durão M, Jr., et al. Tumour necrosis factor-α plus interleukin-10 low producer phenotype predicts acute kidney injury and death in intensive care unit patients. Clin Exp Immunol. 2013;173(2):242-9.
13. Vilander LM, Vaara ST, Kaunisto MA, Pettilä V, Study Group TF. Common Inflammation-Related Candidate Gene Variants and Acute Kidney Injury in 2647 Critically Ill Finnish Patients. J Clin Med. 2019;8(3):342.
14. Gao J-w, Zhang A-q, Pan W, Yue C-l, Zeng L, Gu W, et al. Association between IL-6-174G/C polymorphism and the risk of sepsis and mortality: a systematic review and meta-analysis. PloS one. 2015;10(3):e0118843-e.
15. Feng Y, Tang Y, Zhou H, Xie K. A meta-analysis on correlation between interleukin-6 -174G/C polymorphism and end-stage renal disease. Ren Fail. 2017;39(1):350-6.
16. Panayides A, Ioakeimidou A, Karamouzos V, Antonakos N, Koutelidakis I, Giannikopoulos G, et al. -572 G/C single nucleotide polymorphism of interleukin-6 and sepsis predisposition in chronic renal disease. Eur J Clin Microbiol Infect Dis. 2015;34(12):2439-46.
17. Wuttke M, Köttgen A. Insights into kidney diseases from genome-wide association studies. Nat Rev Nephrol. 2016;12(9):549-62.
18. O’Seaghdha CM, Fox CS. Genome-wide association studies of chronic kidney disease: what have we learned? Nat Rev Nephrol. 2011;8(2):89-99.
19. Solé-Violán J, García-Laorden MI, Marcos-Ramos JA, de Castro FR, Rajas O, Borderías L, et al. The Fcγ receptor IIA-H/H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumonia. Crit Care Med. 2011;39(6):1388-93.
20. Ko GJ, Jang HR, Huang Y, Womer KL, Liu M, Higbee E, et al. Blocking Fas ligand on leukocytes attenuates kidney ischemia-reperfusion injury. J Am Soc Nephrol. 2011;22(4):732-42.
21. Bhatraju P, Hsu C, Mukherjee P, Glavan BJ, Burt A, Mikacenic C, et al. Associations between single nucleotide polymorphisms in the FAS pathway and acute kidney injury. Critical Care. 2015;19(1):368.
22. Takada Y, Andreeff M, Aggarwal BB. Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood. 2005;106(2):641-9.
23. Sue S-C, Alverdi V, Komives EA, Dyson HJ. Detection of a ternary complex of NF-kappaB and IkappaBalpha with DNA provides insights into how IkappaBalpha removes NF-kappaB from transcription sites. Proc Natl Acad Sci U S A. 2011;108(4):1367-72.
24. Pedroso JAR, Paskulin DdA, Dias FS, de França E, Alho CS. Temporal trends in acute renal dysfunction among critically ill patients according to I/D and -262A > T ACE polymorphisms. J Bras Nefrol. 2010;32(2):182-94.
25. Cardinal-Fernández P, Ferruelo A, El-Assar M, Santiago C, Gómez-Gallego F, Martín-Pellicer A, et al. Genetic predisposition to acute kidney injury induced by severe sepsis. J Crit Care. 2013;28(4):365-70.
26. McBride WT, Prasad PS, Armstrong M, Patterson C, Gilliland H, Drain A, et al. Cytokine phenotype, genotype, and renal outcomes at cardiac surgery. Cytokine. 2013;61(1):275-84.
27. Kornek M, Deutsch M-A, Eichhorn S, Lahm H, Wagenpfeil S, Krane M, et al. COMT-Val158Met-polymorphism is not a risk factor for acute kidney injury after cardiac surgery. Disease markers. 2013;35(2):129-34.
28. Albert C, Kube J, Haase-Fielitz A, Dittrich A, Schanze D, Zenker M, et al. Pilot study of association of catechol-O-methyl transferase rs4680 genotypes with acute kidney injury and tubular stress after open heart surgery. Biomark Med. 2014;8(10):1227-38.
29. Popov AF, Hinz J, Schulz EG, Schmitto JD, Wiese CH, Quintel M, et al. The eNOS 786C/T polymorphism in cardiac surgical patients with cardiopulmonary bypass is associated with renal dysfunction. Eur J Cardiothorac Surg. 2009;36(4):651-6.
30. Alam A, O’Connor DT, Perianayagam MC, Kolyada AY, Chen Y, Rao F, et al. Phenylethanolamine N-methyltransferase gene polymorphisms and adverse outcomes in acute kidney injury. Nephron Clin Pract. 2010;114(4):c253-c9.
31. Höcker A, Rabeling M, Bick A, Cox L, Kreuzer M, Engler A, et al. Hypoxia inducible factor-1 alpha and prolinhydroxlase 2 polymorphisms in patients with severe sepsis: a prospective observational trial. BMC Anesthesiology. 2016;16(1):61.
32. Eltzschig HK, Carmeliet PJNEJoM. Hypoxia and inflammation. 2011;364(7):656-65.
33. Leaf DE, Body SC, Muehlschlegel JD, McMahon GM, Lichtner P, Collard CD, et al. Length Polymorphisms in Heme Oxygenase-1 and AKI after Cardiac Surgery. J Am Soc Nephrol. 2016;27(11):3291-7.
34. Saukkonen K, Lakkisto P, Kaunisto MA, Varpula M, Voipio-Pulkki L-M, Varpula T, et al. Heme oxygenase 1 polymorphisms and plasma concentrations in critically ill patients. Shock. 2010;34(6):558-64.
35. Vilander LM, Vaara ST, Donner KM, Lakkisto P, Kaunisto MA, Pettilä V, et al. Heme oxygenase-1 repeat polymorphism in septic acute kidney injury. PloS one. 2019;14(5):e0217291-e.
36. Lu JCT, Coca SG, Patel UD, Cantley L, Parikh CR, Translational Research Investigating B, et al. Searching for genes that matter in acute kidney injury: a systematic review. Clinical journal of the American Society of Nephrology : CJASN. 2009;4(6):1020-31.
37. Perianayagam MC, Tighiouart H, Liangos O, Kouznetsov D, Wald R, Rao F, et al. Polymorphisms in the myeloperoxidase gene locus are associated with acute kidney injury-related outcomes. Kidney Int. 2012;82(8):909-19.
38. Perianayagam MC, Tighiouart H, Nievergelt CM, O’Connor DT, Liangos O, Jaber BL. CYBA Gene Polymorphisms and Adverse Outcomes in Acute Kidney Injury: A Prospective Cohort Study. Nephron Extra. 2011;1(1):112-23.
39. Popov AF, Schulz EG, Schmitto JD, Coskun KO, Tzvetkov MV, Kazmaier S, et al. Relation between renal dysfunction requiring renal replacement therapy and promoter polymorphism of the erythropoietin gene in cardiac surgery. Artif Organs. 2010;34(11):961-8.
40. Henao-Martínez AF, Agler AH, LaFlamme D, Schwartz DA, Yang IV. Polymorphisms in the SUFU gene are associated with organ injury protection and sepsis severity in patients with Enterobacteriacea bacteremia. Infect Genet Evol. 2013;16:386-91.